Celcuity’s stock jumps after Phase 3 trial shows gedatolisib slashes progression risk in breast cancer patients by up to 76%.

XRP gains 3% today as large holders reduce exchange activity by 93%, hinting at growing accumulation. Here's what we expect today.

Now one of Boots' most popular beauty boxes, thanks to its premium beauty and makeup products at an eye-watering reduction, ...